Cargando…

Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials

BACKGROUND: Sending a social norms feedback letter to general practitioners who are high prescribers of antibiotics has been shown to reduce antibiotic prescribing. The 2017-9 Quality Premium for primary care in England sets a target for broad-spectrum prescribing, which should be at or below 10% of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gold, Natalie, Sallis, Anna, Saei, Ayoub, Arambepola, Rohan, Watson, Robin, Bowen, Sarah, Franklin, Matija, Chadborn, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206287/
https://www.ncbi.nlm.nih.gov/pubmed/35717262
http://dx.doi.org/10.1186/s13063-022-06373-y
_version_ 1784729307084488704
author Gold, Natalie
Sallis, Anna
Saei, Ayoub
Arambepola, Rohan
Watson, Robin
Bowen, Sarah
Franklin, Matija
Chadborn, Tim
author_facet Gold, Natalie
Sallis, Anna
Saei, Ayoub
Arambepola, Rohan
Watson, Robin
Bowen, Sarah
Franklin, Matija
Chadborn, Tim
author_sort Gold, Natalie
collection PubMed
description BACKGROUND: Sending a social norms feedback letter to general practitioners who are high prescribers of antibiotics has been shown to reduce antibiotic prescribing. The 2017-9 Quality Premium for primary care in England sets a target for broad-spectrum prescribing, which should be at or below 10% of total antibiotic prescribing. We tested a social norm feedback letter that targeted broad-spectrum prescribing and the addition of a chart to a text-only letter that targeted overall prescribing. METHODS: We conducted three 2-armed randomised controlled trials, on different groups of practices: Trial A compared a broad-spectrum message and chart to the standard-practice overall prescribing letter (practices whose percentage of broad-spectrum prescribing was above 10% and who had relatively high overall prescribing). Trial C compared a broad-spectrum message and a chart to a no-letter control (practices whose percentage of broad-spectrum prescribing was above 10% and who had relatively moderate overall prescribing). Trial B compared an overall-prescribing message with a chart to the standard practice overall letter (practices whose percentage of broad-spectrum prescribing was below 10% but who had relatively high overall prescribing). Letters were posted to general practitioners, timed to be received on 1 November 2018. The primary outcomes were practices’ percentage of broad-spectrum prescribing (trials A and C) and overall antibiotic prescribing (trial B) each month from November 2018 to April 2019 (all weighted by the number and characteristics of patients registered in the practice). RESULTS: We randomly assigned 1909 practices; 58 closed or merged during the trial, leaving 1851 practices: 385 in trial A, 674 in trial C, and 792 in trial B. AR(1) models showed that there were no statistically significant differences in our primary outcome measures: trial A β = − .199, p = .13; trial C β = .006, p = .95; trial B β = − .0021, p = .81. In all three trials, there were statistically significant time trends, showing that overall antibiotic prescribing and total broad-spectrum prescribing were decreasing. CONCLUSION: Our broad-spectrum feedback letters had no effect on broad-spectrum prescribing; adding a bar chart to a text-only letter had no effect on overall antibiotic prescribing. Broad-spectrum and overall prescribing were both decreasing over time. TRIAL REGISTRATION: ClinicalTrials.gov NCT03862794. March 5, 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06373-y.
format Online
Article
Text
id pubmed-9206287
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-92062872022-06-19 Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials Gold, Natalie Sallis, Anna Saei, Ayoub Arambepola, Rohan Watson, Robin Bowen, Sarah Franklin, Matija Chadborn, Tim Trials Research BACKGROUND: Sending a social norms feedback letter to general practitioners who are high prescribers of antibiotics has been shown to reduce antibiotic prescribing. The 2017-9 Quality Premium for primary care in England sets a target for broad-spectrum prescribing, which should be at or below 10% of total antibiotic prescribing. We tested a social norm feedback letter that targeted broad-spectrum prescribing and the addition of a chart to a text-only letter that targeted overall prescribing. METHODS: We conducted three 2-armed randomised controlled trials, on different groups of practices: Trial A compared a broad-spectrum message and chart to the standard-practice overall prescribing letter (practices whose percentage of broad-spectrum prescribing was above 10% and who had relatively high overall prescribing). Trial C compared a broad-spectrum message and a chart to a no-letter control (practices whose percentage of broad-spectrum prescribing was above 10% and who had relatively moderate overall prescribing). Trial B compared an overall-prescribing message with a chart to the standard practice overall letter (practices whose percentage of broad-spectrum prescribing was below 10% but who had relatively high overall prescribing). Letters were posted to general practitioners, timed to be received on 1 November 2018. The primary outcomes were practices’ percentage of broad-spectrum prescribing (trials A and C) and overall antibiotic prescribing (trial B) each month from November 2018 to April 2019 (all weighted by the number and characteristics of patients registered in the practice). RESULTS: We randomly assigned 1909 practices; 58 closed or merged during the trial, leaving 1851 practices: 385 in trial A, 674 in trial C, and 792 in trial B. AR(1) models showed that there were no statistically significant differences in our primary outcome measures: trial A β = − .199, p = .13; trial C β = .006, p = .95; trial B β = − .0021, p = .81. In all three trials, there were statistically significant time trends, showing that overall antibiotic prescribing and total broad-spectrum prescribing were decreasing. CONCLUSION: Our broad-spectrum feedback letters had no effect on broad-spectrum prescribing; adding a bar chart to a text-only letter had no effect on overall antibiotic prescribing. Broad-spectrum and overall prescribing were both decreasing over time. TRIAL REGISTRATION: ClinicalTrials.gov NCT03862794. March 5, 2019. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13063-022-06373-y. BioMed Central 2022-06-18 /pmc/articles/PMC9206287/ /pubmed/35717262 http://dx.doi.org/10.1186/s13063-022-06373-y Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gold, Natalie
Sallis, Anna
Saei, Ayoub
Arambepola, Rohan
Watson, Robin
Bowen, Sarah
Franklin, Matija
Chadborn, Tim
Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title_full Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title_fullStr Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title_full_unstemmed Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title_short Using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
title_sort using text and charts to provide social norm feedback to general practices with high overall and high broad-spectrum antibiotic prescribing: a series of national randomised controlled trials
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9206287/
https://www.ncbi.nlm.nih.gov/pubmed/35717262
http://dx.doi.org/10.1186/s13063-022-06373-y
work_keys_str_mv AT goldnatalie usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT sallisanna usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT saeiayoub usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT arambepolarohan usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT watsonrobin usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT bowensarah usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT franklinmatija usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials
AT chadborntim usingtextandchartstoprovidesocialnormfeedbacktogeneralpracticeswithhighoverallandhighbroadspectrumantibioticprescribingaseriesofnationalrandomisedcontrolledtrials